GGrantIndex
← Search

ADVANCING IMMUNOTHERAPY IN BREAST CANCER LOCAL REPROGRAMMING OF TUMOR-ASSOCIATED MACROPHAGES WITH NOVEL BIOMATERIALS FOR SYSTEMIC ADAPTIVE ANTICANCER

$387,268FY2019Defense Health AgencyDOD

Vanderbilt University Medical Center, Nashville TN

Investigators

View source on USAspending →